TAC1, tachykinin precursor 1, 6863

N. diseases: 478; N. variants: 0
Disease: Prostate carcinoma ×
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0600139
Disease: Prostate carcinoma
Prostate carcinoma 		0.060 AlteredExpression disease BEFREE In conclusion, Ad-PL-PPT-E1A exhibited enhanced antitumor activity is a promising approach for gene therapy of advanced PC. 24849040 2014
CUI: C0600139
Disease: Prostate carcinoma
Prostate carcinoma 		0.060 Biomarker disease BEFREE Preclinical safety assessment of Ad[I/PPT-E1A], a novel oncolytic adenovirus for prostate cancer. 24649837 2014
CUI: C0600139
Disease: Prostate carcinoma
Prostate carcinoma 		0.060 Biomarker disease BEFREE Therefore, we conclude that Ad[i/PPT-E1A, E3] is a prostate-specific oncolytic adenovirus with a high potential for treating localized prostate cancer. 18188185 2008
CUI: C0600139
Disease: Prostate carcinoma
Prostate carcinoma 		0.060 AlteredExpression disease BEFREE Two-step amplification of the human PPT sequence provides specific gene expression in an immunocompetent murine prostate cancer model. 17053814 2007
CUI: C0600139
Disease: Prostate carcinoma
Prostate carcinoma 		0.060 Biomarker disease BEFREE In conclusion, Ad[I/PPT-E1A] may prove to be useful in the treatment of localized prostate cancer. 16052227 2006
CUI: C0600139
Disease: Prostate carcinoma
Prostate carcinoma 		0.060 Biomarker disease BEFREE Neutral endopeptidase (NEP) is a cell-surface bound enzyme that cleaves and inactivates neuropeptides such as bombesin and substance P and is involved in the transition from hormonally regulated androgen-dependent prostate cancer (PC) to androgen-independent PC. 14673956 2004